Extended Data Table 1.

Baseline characteristics

*In patients for whom co-occurring mutation data were available and assessed at each site.

AML, acute myeloid leukaemia; ALL, acute lymphoblastic leukaemia; FLT3, fms-related tyrosine kinase; HSCT, haematopoietic stem cell transplant; MPAL, mixed phenotype acute leukaemia; RAS, rat sarcoma virus.

All values are shown as n (%) except otherwise indicated.